Mohamed Tariq Daouda

Mohamed Tariq Daouda is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of minor histocompatibility antigens through his innovative methods. With a total of two patents to his name, Daouda is recognized for his advancements in medical research.

Latest Patents

Daouda's latest patents focus on a novel method for identifying minor histocompatibility antigens (MiHAs). This method describes the discovery of novel MiHAs and their potential uses. One of the key features of this method is the incorporation of personalized translated transcriptome and/or exome in the database utilized for peptide identification by mass spectroscopy (MS). Candidate MiHAs are identified by comparing the personalized transcriptome and/or exome to a reference genome and/or to the transcriptome and/or exome of an HLA-matched subject.

Career Highlights

Daouda is affiliated with the Université de Montréal, where he continues to contribute to groundbreaking research. His work has implications for improving transplant compatibility and understanding immune responses.

Collaborations

Some of his notable coworkers include Claude Perreault and Pierre Thibault, who have collaborated with him on various research projects.

Conclusion

Mohamed Tariq Daouda's innovative methods in identifying minor histocompatibility antigens represent a significant advancement in medical research. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.